Price T Rowe Associates Inc. MD Acquires 90,604 Shares of Select Medical Holdings Co. (NYSE:SEM)

Price T Rowe Associates Inc. MD raised its holdings in Select Medical Holdings Co. (NYSE:SEM) by 0.5% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,202,219 shares of the health services provider’s stock after acquiring an additional 90,604 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 13.23% of Select Medical worth $518,647,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of the business. Allspring Global Investments Holdings LLC grew its position in shares of Select Medical by 6.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after buying an additional 405 shares in the last quarter. Watershed Asset Management L.L.C. grew its position in shares of Select Medical by 8.2% during the 4th quarter. Watershed Asset Management L.L.C. now owns 10,760 shares of the health services provider’s stock worth $253,000 after buying an additional 814 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Select Medical by 1.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 47,310 shares of the health services provider’s stock worth $1,112,000 after buying an additional 858 shares in the last quarter. Texas Permanent School Fund Corp grew its position in shares of Select Medical by 1.4% during the 1st quarter. Texas Permanent School Fund Corp now owns 92,013 shares of the health services provider’s stock worth $2,774,000 after buying an additional 1,230 shares in the last quarter. Finally, GAMMA Investing LLC bought a new position in shares of Select Medical during the 4th quarter worth $33,000. Institutional investors own 89.48% of the company’s stock.

Select Medical Stock Up 0.7 %

NYSE SEM traded up $0.28 during trading on Monday, hitting $39.55. The company’s stock had a trading volume of 78,953 shares, compared to its average volume of 601,961. The company has a debt-to-equity ratio of 2.30, a current ratio of 1.22 and a quick ratio of 1.22. The company has a market cap of $5.14 billion, a PE ratio of 18.87, a P/E/G ratio of 1.87 and a beta of 1.43. The business’s 50 day simple moving average is $35.29 and its 200-day simple moving average is $30.78. Select Medical Holdings Co. has a fifty-two week low of $21.28 and a fifty-two week high of $40.20.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, May 2nd. The health services provider reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.55 by $0.22. Select Medical had a return on equity of 18.11% and a net margin of 3.97%. The firm had revenue of $1.79 billion during the quarter, compared to the consensus estimate of $1.70 billion. On average, equities analysts anticipate that Select Medical Holdings Co. will post 2.1 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 30th. Investors of record on Thursday, May 16th were issued a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date was Wednesday, May 15th. Select Medical’s dividend payout ratio (DPR) is 23.81%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on SEM. Royal Bank of Canada upped their price objective on Select Medical from $36.00 to $40.00 and gave the stock an “outperform” rating in a research note on Monday, May 6th. Benchmark upped their price objective on Select Medical from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Tuesday, July 16th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $36.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.